KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Change in Intangibles (2017 - 2025)

Amneal Pharmaceuticals has reported Change in Intangibles over the past 9 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Change in Intangibles at $3.0 million for Q4 2025, up 400.0% from a year ago — trailing twelve months through Dec 2025 was $15.5 million (up 5.9% YoY), and the annual figure for FY2025 was $15.5 million, up 5.9%.
  • Change in Intangibles for Q4 2025 was $3.0 million at Amneal Pharmaceuticals, down from $7.4 million in the prior quarter.
  • Over the last five years, Change in Intangibles for AMRX hit a ceiling of $31.8 million in Q3 2022 and a floor of $338000.0 in Q1 2023.
  • Median Change in Intangibles over the past 5 years was $2.1 million (2021), compared with a mean of $6.0 million.
  • Peak annual rise in Change in Intangibles hit 2769.82% in 2024, while the deepest fall reached 96.98% in 2024.
  • Amneal Pharmaceuticals' Change in Intangibles stood at $1.2 million in 2021, then surged by 2550.0% to $31.8 million in 2022, then crashed by 37.42% to $19.9 million in 2023, then crashed by 96.98% to $600000.0 in 2024, then surged by 400.0% to $3.0 million in 2025.
  • The last three reported values for Change in Intangibles were $3.0 million (Q4 2025), $7.4 million (Q3 2025), and $900000.0 (Q2 2025) per Business Quant data.